Cardioneuroablation for atrioventricular block: two decades from concept to a same-session rescue Authors: Jose Carlos Pachon-M, Carlos Thiene C Pachon, Enrique I Pachon-M, Tomas G Santillana-P Published: 2026 An unwelcome complication and an unusual rescue Every electrophysiologist who performs slow-pathway ablation shares a recurring concern: the risk of atrioventricular (AV) block. AV nodal reentrant tachycardia (AVNRT) is the most common regular supraventricular tachycardia, and slow-pathway (SP) modification is among the most frequently performed ablations in the electrophysiology laboratory. Although the technique is highly safe, it retains an inherent hazard, the induction of AV block, an iatrogenic complication that still occurs in approximately 2–3% of procedures. This vulnerability reflects anatomy rather than technique: the slow pathway and the compact node occupy the same triangle of Koch, so the therapeutic target and the structure to be preserved lie only millimeters apart. When the block is permanent, it mandates a pacemaker, committing the patient to lifelong device therapy, with its attendant lead-related risks, generator replacements, and the potential for dyssynchrony associated with chronic right-ventricular pacing. Against this background, Landra and colleagues report a noteworthy observation [1]. A man in his early fifties, undergoing SP ablation for recurrent AVNRT, developed, during the final radiofrequency (RF) application, rapid junctional beats followed by loss of retrograde conduction, the characteristic signature of AV nodal injury. The findings progressed to complete AV block that ultimately stabilized as a persistent 2:1 nodal block. The block was unequivocally nodal: the His–ventricular (HV) interval was preserved at 35 ms, and the blocked P waves showed no His potential. There was no split of H. This was a clearly iatrogenic event that, after 30 min of observation, showed no sign of reversal, leaving the patient symptomatic with presyncope and dyspnea. Rather than proceeding to device implantation, the operators performed cardioneuroablation (CNA) of the inferior paraseptal ganglionated plexus (IPSGP) and acutely restored 1:1 conduction, which was maintained at two-month follow-up. To our knowledge, this is the first reported use of CNA to reverse an iatrogenic nodal block in the acute phase, during the index procedure itself. A twenty-year story: the evolution of CNA for AV block The use of CNA for AV block should be considered against a background of at least two decades, since the origin of a procedure is easily overlooked whenever a new report is presented as “the first.” CNA was conceived in the 1990s and first described in the literature by our group in 2005 [2]. Originally based on the endocardial RF ablation of atrial AF-Nests, fibrillar atrial myocardium with a high probability of vagal innervation interface, and of the atrial ganglionated plexi through a transatrial approach, CNA is designed to achieve durable attenuation of vagal input for conditions mediated by excessive vagal effect: neurocardiogenic syncope, functional AV block, sinus-node dysfunction, and atrial fibrillation. Underlying that concept was a shift in perspective, in which the AV node is regarded not as a passive conductor but as an autonomically modulated structure whose behavior can be re-tuned rather than bypassed. The premise that the autonomic supply to the AV node can be reduced by ablation is therefore more than twenty years old. As early as 2006, we reported the use of CNA to rescue high-degree AV block in a 23-year-old woman with recurrent syncope in the chronic phase after bariatric surgery, thereby avoiding pacemaker implantation [3]. That report provided an early demonstration that an excessively inhibited AV node, in the presence of an intact His–Purkinje system, can be salvaged by reducing its autonomic drive. This application subsequently extended to ablation-related complications. In 2010, Klank-Szafran et al. described the first CNA for AV block after AVNRT ablation [4]. The approach was further developed in the reports of Bulava et al. (2020) [5], Vassallo et al. (2020) [6], and, more recently, San Antonio et al. (2025) [7]. A feature common to all of these reports was temporal: the block manifested and was treated days, months, or years after the index procedure, invariably as a second, elective, and separate intervention. The notable contribution of Landra et al. lies in the compression of that interval. The authors applied CNA within minutes of the unintended thermal injury, during the same index session. In doing so, they converted a deferred, staged strategy, “return in three months for a pacemaker or a possible CNA”, into an immediate, proactive rescue performed before the patient leaves the laboratory. This approach spares the patient the uncertainty of a prolonged wait, the symptoms of intraprocedural low output, and the morbidity of a second intervention. The paradox at the heart of this case: a lesion to correct a lesion? The most conceptually challenging aspect of this report is the treatment of one lesion with another. Both the original description of CNA [2] and the 2024 EHRA/HRS/APHRS/LAHRS [8] consensus indicate that CNA should be reserved for functional AV block, produced exclusively by excessive parasympathetic tone acting on an anatomically intact conduction system. In this patient, however, there were clear indicators of intrinsic thermal nodal injury: fast junctional beats, loss of retrograde conduction, and features of a non-reflex AV block. This observation reinforces the view that “functional” and “structural” are not mutually exclusive categories but components of a single dynamic balance. Instantaneous 1:1 AV conduction represents the intrinsic nodal reserve minus vagal inhibition (Fig. 1-A). Conduction thus possesses a functional reserve, analogous to contractile or renal filtration reserve, and block emerges only when the net dromotropic drive falls below the threshold required for consistent 1:1 capture. If a node has lost part of its myogenic reserve and dromotropism to a partial lesion (Fig. 1-B), it may still return to 1:1 conduction provided the basal parasympathetic “brake” is proportionally reduced or eliminated (Fig. 1-C). The node need not be subject to pathologically elevated vagal tone for denervation to be beneficial; it is sufficient that the reduced population of surviving cells no longer tolerates even a normal residual tone. The authors demonstrated this residual autonomic responsiveness directly: isoproterenol infusion transiently improved conduction, and the block returned as the drug dissipated. Sympathetic augmentation and parasympathetic withdrawal therefore converge on the same endpoint from opposite directions, providing two complementary lines of evidence that the surviving node remained autonomically responsive. A further methodological strength was the deliberate avoidance of atropine, whose long half-life would have transiently restored conduction and obscured the immediate anatomical effect of RF at the ganglion. A: Under physiological conditions, AV conduction remains 1:1 because vagal tone (VT) is balanced by the intrinsic AV-node cell population (IAVN). B: A partial lesion of the nodal cells, for example, during catheter ablation of AV-nodal reentrant tachycardia, reduces the IAVN, leaving vagal tone relatively excessive; the resulting imbalance produces functional AV block. C: Cardioneuroablation (CNA) lowers vagal tone and re-establishes the balance with the reduced number of nodal cells, restoring 1:1 AV conduction and treating the block. Was it the ablation, or was it time? A recognized objection inevitably arises: an edematous nodal lesion frequently recovers spontaneously, and time could have been the actual cause of recovery. In an isolated case report, chance cannot be entirely excluded; nevertheless, the causal evidence here is unusually strong. The restoration of 1:1 conduction was abrupt and sustained, occurring within approximately 2 s of application at the precise target, a latency far too short to be explained by spontaneous resolution of edema. The topography of the intervention was equally informative. Ablation from the right atrium produced only a transient benefit, whereas durable conduction emerged only after transseptal access to the left atrium, the same information described in the original CAN article for AV block treatment. There, using the CARTO ELEVATE module, an analogue of the FRACTIONATION MAPPING algorithm that our group originally developed in 2006 (St. Jude Medical, USA), the operators identified complex, fractionated electrograms corresponding to the AF-Nests and consolidated autonomic modulation of the IPSGP. The reproducibility of block interruption, the short latency, and the anatomical specificity together provide the strongest causal inference attainable from a single case. Recommendations and the future of the therapy Enthusiasm for this same-session rescue should be tempered by appropriate caution. With a single patient and an early two-month follow-up, the durability of the result remains to be established. Even if one assumes that the organic lesion would have resolved spontaneously within days or weeks of the acute event, the authors’ approach remains valid and well founded, since the patient could not have been discharged without a device in the presence of signs and symptoms of low output. In other words, even a transient benefit from CNA would have been clinically decisive and justified. Conversely, late parasympathetic reinnervation, over months or years, may eventually reinstate the block. However, provided a response to atropine persists, a late CNA can restore normal conduction in that later phase as well. Management remains well defined by rigorous patient selection at any stage of the disease. An advantage of CNA is its predictability, based on the simplicity of the atropine test: infranodal disease (the His bundle and His–Purkinje system), which lacks substantial parasympathetic modulation, does not respond to atropine and therefore constitutes a contraindication to CNA. The same applies to advanced nodal lesions with a markedly reduced atropine response. A prolonged HV interval, a widened His potential, or a persistent split His remain unequivocal indications for pacemaker implantation. Moreover, the availability of a CNA “antidote” should not encourage a less rigorous approach during SP ablation; careful attention to established danger markers and to the appearance of anomalous junctional rhythms remains essential. For example, STOP RF IMMEDIATELY if there is loss of retrograde (VA) conduction during junctional beats; if appears fast/accelerated junctional rhythm (>∼120–130 bpm); if there is any PR or AH prolongation, or any AV block; and finally, if there is abrupt change in junctional rate or loss of atrial capture. Lastly, with respect to proarrhythmic concerns, recent work from our group has demonstrated the safety of selective junctional denervation in relation to ventricular refractoriness [9]. By using extracardiac vagal stimulation it was clearly demonstrated that the vagal effect drastically reduces the atrial refractory period while causes absolutely nothing in the ventricular refractory period [9]. Therefore, the CNA, instead of having proarrhythmic has antiarrythmic effect. In conclusion, Landra and colleagues make an important contribution to electrophysiology by demonstrating that, despite anatomical injury and an initially unfavorable prognosis, immediate autonomic modulation can have substantial acute therapeutic value. More than twenty years after cardioneuroablation was first conceived, its conceptual foundations align closely with the management of one of the most feared complications in the ablation laboratory. Footnotes Comment on: Landra F, Peirone A, Marconetto C, Racca E, Taravelli E. Cardioneuroablation for the treatment of acute iatrogenic atrioventricular block during slow pathway ablation procedure. Indian Pacing Electrophysiol J 2026. https://doi.org/10.1016/j.ipej.2026.04.003. References